http://www.fpnotebook.com/
HivesAka: Urticaria
- See Also
- Epidemiology
- Common (U.S. Prevalence up to 25%)
- Pathophysiology
- Response to histamine release from cutaneous mast cells
- Often seen with Angioedema
- Causes
- Allergic Urticaria
- Type I Hypersensitivity (IgE mediated immediate)
- See Allergic Reaction
- Medication reaction (e.g. Penicillins)
- Airborne allergans (e.g. pollens, mold spores)
- Hymenoptera Stings
- Parasitic Infection
- Illness
- Acute Infection
- Generalized inflammation
- Food reaction (e.g. Eggs, Nuts, gluten, shellfish)
- Transient in children (rare in adults)
- Must occur within minutes of exposure
- Type II Hypersensitivity (Cell mediated cytotoxicity)
- Transfusion Reaction
- Type III Hypersensitivity (Antigen-Antibody complex)
- Type I Hypersensitivity (IgE mediated immediate)
- Autoimmune condition
- Hashimoto's Thyroiditis
- Systemic Lupus Erythematosus
- Chronic active hepatitis
- Viral Infection
- Herpes Simplex Virus (HSV)
- Cytomegalovirus (CMV)
- Epstein-Barr Virus (EBV)
- Direct mast cell degranulation
- Narcotics
- Vancomycin
- Aspirin
- Anaphylactoid Reaction to Radiocontrast
- Dextran
- Muscle relaxants
- NSAIDs
- Ingestion of foods concentrated in histamine
- Strawberries
- Tomatoes
- Shrimp or lobster
- Cheese
- Spinach
- Eggplant
- Emotional Stress
- Physical Urticaria
- Cold Urticaria
- Affects hands, ear, nose and lateral thighs
- Cholinergic Urticaria
- Fever
- Hot baths
- Exercise-Induced Urticaria
- Solar Urticaria (Sun induced)
- Pressure
- Tight clothing
- Soles of foot and other weight bearing points
- Dermatographism
- Cold Urticaria
- Allergic Urticaria
- Types
- Acute Urticaria (present hours to weeks)
- Idiopathic in 75% of cases
- Chronic Urticaria (persistent beyond 6 weeks)
- Idiopathic in 95% of cases
- May be related to autoantibody to IgE
- Acute Urticaria (present hours to weeks)
- Symptoms
- Signs
- Characteristics
- Hives or wheals up to 1-2 centimeters in size
- Redness and edema of Dermis
- Spread with scratching and coalesce into large patch
- Course of Lesions
- Lesions last 90 minutes to 24 hours
- Associated findings
- Characteristics
- Evaluation
- Recommended diagnostics
- Careful History
- Negative history makes finding cause very unlikely
- Travel and work history
- Ingestion of foods, medications, herbals, vitamins
- Recent infection
- Known allergies
- Family History of allergy or Thyroid disease
- Lab Tests
- Only if suggested by specific symptoms or signs
- Consider brief panel if suggested by history
- Complete Blood Count with differential
- Urinalysis
- Erythrocyte Sedimentation Rate (ESR)
- Liver Function Tests
- Thyroid Stimulating Hormone (TSH)
- Skin biopsy if lesion present >24 hours
- Consider urticarial Vasculitis
- Painful or burning leg lesions
- Biopsy show Neutrophilic infiltrate
- Careful History
- Diagnostic tests that are not recommended
- Radiologic studies
- Sinus XRay and Dental XRay have low yield
- Allergy Testing
- Not helpful in chronic urticaria
- Radiologic studies
- Recommended diagnostics
- Differential Diagnosis
- See also Wheal
- Urticarial Vasculitis (Leukocytoclastic Vasculitis)
- Painful leg lesions last 3-5 days
- Consider biopsy (shows Neutrophilic infiltrate)
- Management: General
- Observe for severe Allergic Reaction
- See Anaphylaxis
- Discontinue offending drugs, food, or behavior
- Offer Reassurance
- Discuss idiopathic nature of chronic urticaria
- Unlikely to identify a specific cause
- Explain that diagnostics and labs are not indicated
- Observe for severe Allergic Reaction
- Management
- Step 1: Non-Sedating Antihistamines
- Step 2: Sedating Antihistamines
- Consider for nighttime and refractory to step 1
- Hydroxyzine (Atarax) is the most potent of the class
- Beware Sedation in older patients and fall risk
- Indications and effects
- Helpful in Acute Hives in first few weeks
- Suppresses itching, and reduces lesions
- Does not completely eradicate lesions
- Step 3: Add H2 Receptor Antagonist
- H2 Blockers are rarely helpful
- Ranitidine 150 mg PO bid or
- Cimetidine 400 mg PO bid
- Step 4: Add combined H1 and H2 Receptor Antagonist
- Doxepin (Sinequan)
- Dose: 25-75 mg PO qhs
- Very potent Antihistamine (H1 and H2 Blocker)
- Cyproheptadine (Periactin) 4 mg PO tid
- Doxepin (Sinequan)
- Step 5: Leukotriene modifier
- Montelukast (Singulair) 10 mg PO qd
- Zafirlukast (Accolate) 20 mg PO bid
- Step 6: Systemic Corticosteroids
- Prednisone 20-40 mg PO qd
- Indication
- Chronic urticaria not responding to Antihistamines
- Unlikely to help in early or acute urticaria
- Efficacy
- Process will flare when steroids are weaned
- Step 7: Consult allergy or dermatology
- Resources
- Wanderer (2003) Hives: Road to Diagnosis and Treatment
- References
- Frank in Goldman (2000) Cecil Medicine, p. 1440-5
- Kaplan in Middleton (1998) Allergy, p. 1104-18
- Habif (1996) Clinical Dermatology, p. 122-47
- Greaves (2000) J Allergy Clin Immunol 105:664
- Muller (2004) Am Fam Physician 69(5):1123
Urticaria (C0042109) | |
|---|---|
| Definition (MSH) | A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. |
| Definition (CSP) | usually transient vascular reaction involving the upper dermis, representing local edema caused by dilation and increased permeability of the capilliaries and the development of wheals. |
| Definition (NCI) | Urticaria. |
| Definition (NCI) | An itchy skin eruption characterized by weals with pale interiors and well-defined red margins; usually the result of an allergic response to insect bites or food or drugs. |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 708, 708.9, 708.9 |
| MSH | D014581 |
| Basque | URTIKARIA |
| Danish | Urticaria |
| Dutch | Urticaria |
| English | Hive, Hives, RASH URTICARIAL, Unspecified urticaria, Urticaria, Urticarial rash, Urticarias |
| Finnish | NOKKOSROKKO/URTICARIA |
| French | Urticaire |
| German | Urtikaria |
| Hebrew | urtikaria |
| Hungarian | urticaria |
| Italian | Orticaria |
| Norwegian | ELVEBLEST/URTICARIA l50 |
| Portuguese | Urticaria |
| Spanish | erupcion urticariana, papula urticariana, Urticaria |
| Swedish | NASSELUTSLAG/URTICARIA |
| Parent Concepts | Dermatitis (C0011603), skin disorder (C0037274), Exanthema (C0015230), Hypersensitivity (C0020517), Dermatoses, General and NEC (C0549580), Urticaria (C0042109), Other skin and subcutaneous tissue disease NOS (C0178301), Diagnosis/Diseases Component (C0497531), Skin (C1123023), Immediate hypersensitivity (C0020523), Skin Diseases, Vascular (C0162819), Edematous skin (C0521464), Edema (C0013604), Ambiguous concept (C1274012), Duplicate concept (C1274013) |
| Sources | AOD, COSTAR, CSP, CST, DXP, ICD9CM, ICPC, ICPCBAQ, ICPCDAN, ICPCDUT, ICPCFIN, ICPCFRE, ICPCGER, ICPCHEB, ICPCHUN, ICPCITA, ICPCNOR, ICPCPOR, ICPCSPA, ICPCSWE, LCH, MEDLINEPLUS, MSH, MTH, MTHICD9, NCI, NDFRT, OMIM, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
